JUPITER LIFE LINE HOSP L Fair Value
JLHL · Healthcare · Current price ₹289.35
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹253 | 13% ROE fading to 12% over ~10 yrs, on ₹236 book |
| Relative P/E | ₹1,914 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹396 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹341 | Street consensus 12-month target price |
Is JUPITER LIFE LINE HOSP L undervalued?
DocStoX estimates the fair value of JUPITER LIFE LINE HOSP L at ₹670 per share, versus the current market price of ₹289. That puts the stock about +131.7% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹253), Relative P/E (₹1,914), Graham floor (₹396), Analyst target (₹341). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹253 (bear) to ₹670 (base) to ₹1,914 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on JUPITER LIFE LINE HOSP L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.